Original Research
Published on 19 Oct 2020
ERBB2-CAR-Engineered Cytokine-Induced Killer Cells Exhibit Both CAR-Mediated and Innate Immunity Against High-Risk Rhabdomyosarcoma
in Alloimmunity and Transplantation
- 5,326 views
- 24 citations
Original Research
Published on 19 Oct 2020
in Alloimmunity and Transplantation
Original Research
Published on 20 Apr 2018
in Experimental Pharmacology and Drug Discovery
Review
Published on 06 Jul 2017
in Cancer Immunity and Immunotherapy
Review
Published on 22 Aug 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 14 Sep 2022
in NK and Innate Lymphoid Cell Biology
Original Research
Published on 09 Apr 2012
in Pediatric Oncology
Original Research
Published on 07 Oct 2021
in Cancer Immunity and Immunotherapy
Review
Published on 13 May 2015
in NK and Innate Lymphoid Cell Biology
Original Research
Published on 03 Nov 2023
in Evolutionary and Genomic Microbiology
Original Research
Published on 11 May 2022
in Thoracic Oncology
Original Research
Published on 25 Aug 2022
in Cancer Immunity and Immunotherapy
Original Research
Published on 21 Aug 2020
in Cancer Immunity and Immunotherapy
Original Research
Published on 08 Jan 2021
in Comparative Immunology
Original Research
Published on 18 Jul 2014
in Pediatric Oncology
Case Report
Published on 05 Jul 2018
in Cancer Immunity and Immunotherapy
Original Research
Published on 14 Mar 2024
in Cancer Immunity and Immunotherapy